Pituitary & hypothalamus

Growth hormone increase by luteinizing hormone-releasing hormone reflects gonadotroph-related characteristics in acromegaly

PituitaryPublished Comparative clinical study

Authors' conclusion

The increased GH response to LHRH is associated with the gonadotroph-related characteristics. This response may reflect the biological characteristics of somatotroph tumors.

Study context

Population
Patients with acromegaly
Participants
33 vs 81
Comparison
LHRH responders vs LHRH nonresponders
  • LHRH respondersn = 33
  • LHRH nonrespondersn = 81reference
Outcome
Clinical characteristics, especially gonadotroph-related characteristics

Main finding

As reported in the abstract

Gonadotroph-related characteristics
  • SF-1, gonadotropin-releasing hormone receptor (GnRHR) and LH expression more frequent in LHRH responders
  • Tumours with SF-1 expression: greater growth hormone (GH) increase after LHRH loading and higher proportion of GnRHR and gonadotropin expression than tumours without (P < 0.01)
  • No differences in age, sex or basal serum GH, IGF-1 and gonadotropin between groups
  • LHRH responders vs LHRH nonresponders: P < 0.05

Further findings

OutcomeP value
Response to somatostatin analoguesP < 0.05
T2 MRI hypointensity and densely granulated typeP < 0.05
  • Response to somatostatin analogues: greater GH decrease in octreotide test and greater IGF-1 decrease after first-generation SRL in LHRH responders
  • T2 MRI hypointensity and densely granulated type: higher proportion of T2-hypointense and densely granulated tumours in LHRH responders

Somatostatin receptor 2 and 5 expression

No difference between groups in somatostatin receptor 2 or 5 expression

Original publication

Growth hormone increase by luteinizing hormone-releasing hormone reflects gonadotroph-related characteristics in acromegaly. Pituitary. Published 19 June 2024. doi:10.1007/s11102-024-01410-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.